Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trouw

Showing results (121-130 of 283) with videos related to

Pageof 29
Sort By:
Molecular Immunology|October 18, 2008
Complement production and regulation by dendritic cells: molecular switches between tolerance and immunityCees van Kooten, Nicoletta Fiore, Leendert A Trouw, et al.
Annals of the Rheumatic Diseases|February 6, 2015
Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune systemJeroen N Stoop, Anita Fischer, Silvia Hayer, et al.
Scientific Reports|April 15, 2020
Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosisKarin Dijkman, Rosalie Lubbers, Nicole V Borggreven, et al.
International Journal of Antimicrobial Agents|August 1, 1996
In vivo TNF induction by culture supernatants of antibiotic-treated Escherichia coli 07:K1. Role of antibiotic class and concentrationW N Hustinx, B J Benaissa-Trouw, I van der Tweel, et al.
Infection and Immunity|May 25, 1999
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPSC J de Haas, R van der Zee, B Benaissa-Trouw, et al.
Infection and Immunity|November 26, 2003
Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3Dirk J Lefeber, Barry Benaissa-Trouw, Johannes F G Vliegenthart, et al.
Lupus|June 3, 2016
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosusC Magro-Checa, R A Schaarenburg, H J L Beaart, et al.
Annals of the Rheumatic Diseases|March 10, 2017
Identification of Lifelines participants at high risk for development of rheumatoid arthritisS Arends, L A Trouw, R E M Toes, et al.
Vaccine|August 26, 1998
Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccinesI M Fernández, M Harmsen, B J Benaissa-Trouw, et al.
The British Journal of Dermatology|April 29, 2021
Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional studyD J Dijkstra, S I E Liem, N M van Leeuwen, et al.
Pageof 29

Showing results (121-130 of 283) with videos related to

Sort By:
Pageof 29
Molecular Immunology|October 18, 2008
Complement production and regulation by dendritic cells: molecular switches between tolerance and immunityCees van Kooten, Nicoletta Fiore, Leendert A Trouw, et al.
Annals of the Rheumatic Diseases|February 6, 2015
Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune systemJeroen N Stoop, Anita Fischer, Silvia Hayer, et al.
Scientific Reports|April 15, 2020
Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosisKarin Dijkman, Rosalie Lubbers, Nicole V Borggreven, et al.
International Journal of Antimicrobial Agents|August 1, 1996
In vivo TNF induction by culture supernatants of antibiotic-treated Escherichia coli 07:K1. Role of antibiotic class and concentrationW N Hustinx, B J Benaissa-Trouw, I van der Tweel, et al.
Infection and Immunity|May 25, 1999
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPSC J de Haas, R van der Zee, B Benaissa-Trouw, et al.
Infection and Immunity|November 26, 2003
Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3Dirk J Lefeber, Barry Benaissa-Trouw, Johannes F G Vliegenthart, et al.
Lupus|June 3, 2016
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosusC Magro-Checa, R A Schaarenburg, H J L Beaart, et al.
Annals of the Rheumatic Diseases|March 10, 2017
Identification of Lifelines participants at high risk for development of rheumatoid arthritisS Arends, L A Trouw, R E M Toes, et al.
Vaccine|August 26, 1998
Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccinesI M Fernández, M Harmsen, B J Benaissa-Trouw, et al.
The British Journal of Dermatology|April 29, 2021
Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional studyD J Dijkstra, S I E Liem, N M van Leeuwen, et al.
Pageof 29